Beckman Research Institute of The City of Hope

Mystery Gene Glo1 Reveals Novel Anxiety Mechanism via Methylglyoxal and GABA-A Receptors

- Researchers at the University of Chicago demonstrated that the Glo1 gene causally influences anxiety-like behavior through copy number variants, with more copies producing greater anxiety in mice. - The study uncovered that methylglyoxal (MG), a metabolic byproduct lowered by Glo1, rapidly reduces anxiety by directly activating GABA-A receptors on neurons — a previously unknown inhibitory mechanism. - A small molecule Glo1 inhibitor developed at the Beckman Research Institute successfully reduced anxiety-like symptoms in mice, suggesting a new therapeutic strategy distinct from traditional benzodiazepines. - The discovery links neuronal inhibitory tone to metabolic activity, opening potential avenues for treating anxiety disorders, epilepsy, and sleep disorders with greater specificity and fewer side effects.